Pluslife's RNase Hybridization Assisted Amplification (RHAM) technology,a self-invented and patented nucleic acid isothermal amplification detection technology with comparable performance to lab PCR tests.
● Enzymes are optimized by directed evolution to improve performance and tolerance, which is extraction-free.
● Unique probes can amplifysignals through cyclic cleavage, enhancing the system's sensitivity.
● The probe-based recognition& result reporting also ensure the specificity of positive signals.
视频播放失败,请联系站点管理员!
95%~100%
Sensitivity
98%~100%
Specificity
96%~100%
Consistency
Featured Products
-
Mycobacterium Tuberculosis(Sputum/Tongue swab sample)
Tuberculosis (TB), caused by Mycobacterium tuberculosis, primarily affects the lungs, with around 10 million new cases annually as of July 2024. Traditional testing methods are often impractical for rapid diagnosis. Our Mycobacterium Tuberculosis Nucleic Acid Test Card offers a user-friendly solution for detecting MTBC DNA in sputum or tongue swab samples, enabling timely diagnosis and management.¥ 0.00More >
-
SARS-CoV-2/FIu A/Flu B
With the rise of respiratory illnesses like COVID-19, Flu A, and Flu B, efficient and accurate testing is vital. As of July 2024, SARS-CoV-2 has caused over 760 million cases worldwide, and seasonal flu affects millions each year. Quick, precise diagnosis is key to effective management. Traditional methods can be cumbersome for rapid, frequent testing.
This kit provides a streamlined solution for in vitro detection of SARS-CoV-2, Influenza A, and Influenza B RNA in nasal swab samples.¥ 0.00More >
-
HPV 16/18/45
HPV types 16, 18, and 45 are linked to various cancers, notably cervical cancer, with types 16 and 18 causing about 70% of cases. With over 600,000 new cervical cancer cases annually as of July 2024, early screening is crucial. Traditional methods may be slow, delaying follow-up and treatment.
This kit offers rapid detection of HPV types 16, 18, and 45 DNA in cervical and vulvovaginal swabs, aiding early diagnosis and cancer prevention.¥ 0.00More >
-
SARS-CoV-2
Traditional large testing equipment is often impractical for frequent, quick tests. Quick and accurate testing methods are essential for timely diagnosis and effective management of COVID-19 cases. Accurate COVID-19 diagnosis is crucial due to its global impact and high transmission rates.
This kit provides in vitro qualitative detection of the N gene and ORF1ab gene of SARS-CoV-2 in nasal swabs from suspected COVID-19 cases.¥ 0.00More >
News
-
MEDICA 2024: Innovating Molecular Diagnostics to Drive Decentralized Infectious Disease Testing
Pluslife's solutions empower grassroots testing capabilities and bring a whole new experience to visitors at the event.
2024-11-14
-
Africa Health 2024: Showcasing Innovation, Revolutionizing and Decentralizing Infectious Disease Testing
Pluslife Shines at Africa Health 2024, Driving Innovation and Decentralization in Infectious Disease Testing.
2024-10-25
-
Pluslife Secures Indonesian Import License for Groundbreaking Mycobacterium Tuberculosis Nucleic Acid Test Card
Recently, Pluslife's self-developed rapid molecular diagnostic test card for tuberculosis, utilizing tongue swab samples, was awarded an import medical device license by the Indonesian government. This milestone marks a significant breakthrough following the earlier certification of Pluslife’s sputum sample TB diagnostic technology.
2024-09-09
Partnership with BMGF
Pluslife has received a grant from the Bill & Melinda Gates Foundation for our "Sexually Transmitted Infections (STI) Project." This partnership aims to reduce the burden of STIs and improve management and prevention in LMICs.
Collaboration with FIND
Developing the HPV project with FIND for the benefit of women in less developed countries. Pluslife HPV 16/18/45 product exhibits excellent clinical performance.
Validation through PATH
In the APOLLO evaluation project conducted at the PATH laboratory in Seattle, Pluslife MiniDock has gained satisfactory results in terms of test performance and usability, confirming its testing accuracy and strong usability in LMICs.
Contact Us
Tel: +86-20-31703986
E-mail: market@pluslife.com (Business Enquiry)
service@pluslife.com (After-Sales & Technical Support)
Add: 3F-Block E, Runhui Science & Technology Park, No.18 Shenzhou RD, Huangpu District, Guangzhou, Guangdong, China
Copyright © Established